{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:55:33Z","timestamp":1760244933589},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,7,14]],"date-time":"2006-07-14T00:00:00Z","timestamp":1152835200000},"content-version":"vor","delay-in-days":4212,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes Chromosomes &amp; Cancer"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We have previously identified deletions of 9p and 9q in a cytogenetic analysis of a large series of non\u2010Hodgkin's lymphomas (NHLs), which suggested loss of candidate tumor suppressor genes (TSGs). In order to define these deletions at the molecular level, we performed an LOH analysis of a panel of paired normal and tumor DNAs comprising 13 cases of diffuse lymphoma with a large cell component (DLLC) and 18 cases of Burkitt's lymphoma (BL). The loci tested comprised eight polymorphic probes mapped to 9p (D9S33, D9S25, <jats:italic>IFNB, IFNA, IFNW<\/jats:italic>, D9S126, D9S3, and D9S19) and seven polymorphic probes mapped to 9q (D9S29, <jats:italic>ASS, AKI, ABL<\/jats:italic>, D9S10, D9S7, and D9S14). In this analysis, among cases informative for all loci in each subset, 5\/13 (38%) DLLC and 4\/18 (22%) BL showed LOH at 9p loci, whereas 5\/13 (38%) DLLC and 3\/18 (16%) BL showed LOH at 9q loci. Among the 9p loci partial homozygous or heterozygous losses were observed in 20\u201350% of informative cases of DLLC at D9S25, <jats:italic>IFNB, IFNA, IFNW<\/jats:italic>, D9S126, and D9S3, whereas in BL, losses at these loci ranged from 0% to 11%. Among the 9q loci, heterozygous losses were observed in &gt;20% of informative cases of DLLC at D9S7 (23%) and D9S29 (27%), whereas no losses were seen at these two loci in BL. These data demonstrate a high level of molecular deletion in DLLC, but not in BL, suggesting that loss of one or more TSGs on chromosome 9 plays an important role in DLLC development.<\/jats:p>","DOI":"10.1002\/gcc.2870120106","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T00:14:23Z","timestamp":1172103263000},"page":"32-36","source":"Crossref","is-referenced-by-count":20,"title":["Diffuse large cell lymphomas exhibit frequent deletions in 9p21\u201322 and 9q31\u201334 regions"],"prefix":"10.1002","volume":"12","author":[{"given":"Seeta R.","family":"Chaganti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane C.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S. K.","family":"Chaganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Dalla\u2010Favera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,14]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(83)90138-3"},{"key":"e_1_2_1_3_1","first-page":"1230","article-title":"Preliminary mapping of deleted region of chromosome 9 in bladder cancer","volume":"53","author":"Cairns P","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_1_4_1","first-page":"4761","article-title":"Homozygous deletions within 9p21\u201322 identify a small critical region of chromosomal loss in human malignant mesotheliomas","volume":"53","author":"Cheng JQ","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.14.5259"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001113220202"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.10557"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.7.1781.1781"},{"key":"e_1_2_1_9_1","first-page":"3674","article-title":"Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group","volume":"53","author":"James CD","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153634"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"P53 mutations are associated with histologic transformation of follicular lymphoma","volume":"82","author":"LoCoco F","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_12_1","first-page":"640","article-title":"Frequent loss of chromosome 9 in human primary non\u2010small cell lung cancer","volume":"54","author":"Merlo A","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_13_1","first-page":"1152","article-title":"Allelotype of head and neck squamous cell carcinoma","volume":"54","author":"Nawroz H","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870030304"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0889-8588(18)30389-7","article-title":"Chromosomal aberrations in non\u2010Hodgkin's lymphoma","volume":"5","author":"Offit K","year":"1992","journal-title":"Hematol Oncol Clin N Am"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870070102"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.7.2157.2157"},{"key":"e_1_2_1_18_1","first-page":"2523","article-title":"Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas","volume":"52","author":"Olopade OI","year":"1992","journal-title":"Cancer Res"},{"key":"e_1_2_1_19_1","first-page":"2410","article-title":"Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers","volume":"53","author":"Olopade OI","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_1_20_1","first-page":"2848","article-title":"Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors","volume":"54","author":"Orlow I","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_21_1","first-page":"333","volume-title":"Genome Priority Reports","author":"Povey S","year":"1993"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(87)90028-8"},{"key":"e_1_2_1_23_1","first-page":"44","article-title":"Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer","volume":"50","author":"Tsai YC","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8235596"}],"container-title":["Genes, Chromosomes and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fgcc.2870120106","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/gcc.2870120106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T16:45:33Z","timestamp":1698252333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gcc.2870120106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1002\/gcc.2870120106"],"URL":"https:\/\/doi.org\/10.1002\/gcc.2870120106","archive":["Portico"],"relation":{},"ISSN":["1045-2257","1098-2264"],"issn-type":[{"value":"1045-2257","type":"print"},{"value":"1098-2264","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}